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Abstract
ATP-dependent paracrine signaling, mediated via the release of ATP through plasma membrane-embedded hemichannels
of the connexin family, coordinates a synchronized response between neighboring cells. Connexin 43 (Cx43) hemichannels
that are present in the plasma membrane need to be tightly regulated to ensure cell viability. In monolayers of bovine
corneal endothelial cells (BCEC),Cx43-mediated ATP release is strongly inhibited when the cells are treated with
inflammatory mediators, in particular thrombin and histamine. In this study we investigated the involvement of RhoA
activation in the inhibition of hemichannel-mediated ATP release in BCEC. We found that RhoA activation occurs rapidly and
transiently upon thrombin treatment of BCEC. The RhoA activity correlated with the onset of actomyosin contractility that is
involved in the inhibition of Cx43 hemichannels. RhoA activation and inhibition of Cx43-hemichannel activity were both
prevented by pre-treatment of the cells with C3-toxin as well as knock down of RhoA by siRNA. These findings provide
evidence that RhoA activation is a key player in thrombin-induced inhibition of Cx43-hemichannel activity. This study
demonstrates that RhoA GTPase activity is involved in the acute inhibition of ATP-dependent paracrine signaling, mediated
by Cx43 hemichannels, in response to the inflammatory mediator thrombin. Therefore, RhoA appears to be an important
molecular switch that controls Cx43 hemichannel openings and hemichannel-mediated ATP-dependent paracrine
intercellular communication under (patho)physiological conditions of stress.
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Introduction
Intercellular communication can occur through direct and
indirect pathways. Direct signaling is possible via connexin (Cx)-
based gap junction channels that connect the cytoplasm of
adjacent cells. An important indirect manner of intercellular
communication is via paracrine signaling. Unopposed Cx-based
channels present in the plasma membrane, referred to as Cx
‘‘hemichannels’’, are a known conduit for the release of
biomolecules, including purinergic messengers. The activity of
Cx hemichannels is tightly regulated and characterized by a low
open probability under physiological conditions to prevent
deleterious events such as excessive loss of metabolites [1]. The
latter may occur under pathological conditions like inflammation
[2,3], ischemia [4] and oxidative stress [5].
We extensively characterized gap junction- and hemichannel-
mediated intercellular communication in bovine corneal endo-
thelial cells (reviewed in [6]), a model system often used to study
barrier integrity in the corneal endothelium [7]. Our previous
work elucidated that intercellular communication (IC) in these
cells is mainly mediated through paracrine signaling via the
release of ATP through Cx hemichannels consisting of the 43-
kDa isoform (Cx43) [8–10]. Furthermore, this ATP-driven
paracrine IC is inhibited acutely and potently by the application
of thrombin [6,10–13]. Thrombin-induced inhibition of hemi-
channel responses is prevented by pre-treating the cells with
either the Myosin Light Chain kinase (MLCK) inhibitor ML-7,
the Rho-Associated Kinase (ROCK) inhibitor Y-27632 or the
Protein Kinase C (PKC) inhibitor chelerythrine [11,12]. These
pharmacological agents have been demonstrated to prevent
enhancement of MLC-phosphorylation in BCEC upon throm-
bin treatment [14]. By blocking myosin II-mediated cell-
contraction using (–)-blebbistatin, a potent and selective
inhibitor of myosin II ATPase activity, we demonstrated the
necessity of the active non-muscle myosin II-dependent
contractile system in the thrombin-induced inhibition of
hemichannel activity in BCEC [13]. Since Rho GTPases, as
molecular switches, are implicated in the regulation of
actomyosin contractility through the Rho-ROCK-Myosin sig-
naling pathway [15,16], we wanted to investigate the possible
involvement of Rho GTPase activity in the inhibitory action of
thrombin on Cx43-hemichannel activity.
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Results
C3 Prevents Inhibition of Cx43 Hemichannels by
Thrombin
In a previous study, we showed that both thrombin and TRAP-
6 (thrombin receptor activator peptide 6, SFLLRN) inhibit
hemichannel activity through activation of the protease activated
receptor 1 (PAR-1) in BCEC [11]. PAR-1 activation is known to
promote cell contraction and gap formation in confluent
monolayers of endothelial cells, a mechanism that involves the
Rho-Rho kinase pathway [16,17]. Since the C3-exoenzyme of
Clostridium botulinum, potently inhibits Rho GTPase activity by
ADP-ribosylation [18], we applied cell-permeable C3-transferase
(referred to as ‘‘C3’’) while monitoring hemichannel activity (by
investigating either intercellular Ca2z-wave propagation, me-
chanical stimulation induced ATP release and LY uptake) in the
presence and absence of thrombin.
In intercellular Ca2z-wave propagation experiments with
BCEC, the mechanically stimulated cell shows a transient
½Ca2zi rise, which originates at the point of stimulation and
spreads out to the neighboring cells in a wave-like manner. Ca2z-
transients were observed up to approximately four to six cell layers
away from the mechanically stimulated cell. Thrombin-treated
BCEC also show intercellular propagation of the Ca2z wave, but
the spread of the wave is strongly reduced to about two to four cell
layers. Figure 1 shows the quantitative analysis of spreading of the
Ca2z wave, presented as ‘‘Normalized Active Area (AA)’’ (Fig. 1).
Thrombin-treatment reduced the AA by&70% (19.3+ 1.5 mm2
(N = 5, n = 48) versus 66.3 + 5.4 mm2 under control conditions
(N = 5, n = 48)).
No significant difference was found in AA between control and
C3-pretreated BCEC in the absence of thrombin (comparison of
black bars in Fig. 1). C3-pretreatment of BCEC significantly
suppressed the effect of thrombin on the propagation of the Ca2z-
wave (pv0:001; N = 5, n = 48; comparison grey bars, Fig. 1).
Taken together, these findings demonstrate that Rho GTPase
activity is involved in the thrombin-induced inhibition of Ca2z-
wave propagation.
Since the hemichannel-mediated responses of BCEC in Ca2z-
wave propagation experiments are largely dependent on ATP
release [8,9,11,13] via Cx43 hemichannels [10], and because
thrombin was shown previously to reduce ATP release upon
mechanical stimulation [10–13], the effect of C3-pretreatment on
ATP release upon mechanical stimulation was examined.
Thrombin reduced ATP release upon mechanical stimulation by
&57% (N = 5, n = 11, Fig 2), while thrombin did not reduce ATP
release after C3-pretreatment (102% ATP release versus 100%
ATP release in control conditions (N = 5, n = 9), Fig. 2). These
results provide evidence that thrombin-enhanced Rho GTPase
activity is involved in the thrombin-induced inhibition of Cx43-
hemichannel mediated ATP release. We also investigated the
effect of C3 on the opening of Cx hemichannels triggered by
exposure of BCEC to a Ca2z-free solution containing EGTA, by
visualizing the uptake of the hydrophilic dye Lucifer Yellow (LY).
As shown previously [11,12], BCEC take up LY under control
conditions and thrombin potently inhibits this LY uptake (Fig. 3A
and B). However, when cells were pretreated with C3, thrombin
did not inhibit the uptake of LY (Fig. 3D). Since C3 can prevent
the inhibitory effect of thrombin on Cx-hemichannel activity,
these results demonstrate the involvement of a Rho GTPase in the
signaling cascade triggered by thrombin.
C3 Prevents RhoA Activation
Thrombin induces rapidly the activation of RhoA (a Rho
GTPase family member) in endothelial cells [19]. Since RhoA
activation promotes cell contractility by the actin-myosin II system
via the ability of RhoA to regulate the MLC-phosphorylation
status (Rho/ROCK axis), it is plausible that RhoA is an important
Rho GTPase protein involved in the thrombin-induced inhibition
of Cx43-hemichannel activity. Therefore, we measured the time
course of RhoA activation upon stimulation of BCEC with
thrombin for various periods. GTP-bound Rho GTPase proteins
were pulled down from lysates of BCEC using the Rho-binding
domain of human Rhotekin fused to GST (Rhotekin-RBD beads)
and Western blot analysis was performed to monitor active (GTP-
bound) and total RhoA levels in time. Active RhoA levels rapidly
increased (within 30 s) after thrombin application. After 5 min,
active RhoA levels already declined (Fig. 4). When thrombin-
treated BCEC that were pretreated with C3, were analyzed for
their levels of active RhoA using the pull down method, only low
levels of active RhoA were detected (Fig. 5), when compared to
maximal RhoA-activation levels induced by loading of RhoA with
a non-hydrolyzable GTP-analogue (GTPcS).
RhoA Knockdown Overcomes Thrombin-induced
Inhibition of Cx43-hemichannel-driven Intercellular
Communication
To examine the involvement of RhoA in thrombin-induced
inhibition of Cx hemichannel activity, we performed Ca2z-wave
propagation experiments on BCEC approximately 24 hours after
they were transfected with RhoA-targetting siRNA. We previously
have shown that under these conditions more than 95% of the cells
have taken up the siRNA duplexes [10]. In addition, to minimize
off-target effects, we examined independently the effects of two
siRNA-duplexes that target different regions of the RhoA mRNA.
Efficiency of RhoA knockdown by both siRNA-duplexes was
verified by Western-blotting analysis (Fig. 6A), which show a more
than&80% reduction in RhoA-expression levels in comparison to
Figure 1. Effect of C3-pretreatment on the thrombin-induced
inhibition of mechanical stimulation-induced Ca2z-wave
propagation in BCEC. Quantitative analysis of the total spreading
of the mechanical stimulation-triggered Ca2z wave, presented as
active area (AA) normalized to the control condition (100%) in
untreated (white bars) and thrombin-treated (black bars) BCEC, either
in control conditions or in C3-pretreated conditions.  indicates that
thrombin significantly (P v 0.001) inhibits Ca2z-wave propagation.
‘ indicates that C3 significantly (p v 0.001) alleviates the thrombin-
induced inhibition of Ca2z-wave propagation.
doi:10.1371/journal.pone.0042074.g001
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cells transfected with the scrambled siRNA control version. Both
siRhoA-duplexes independently overcome the thrombin-induced
inhibition of Cx hemichannel responses, while hemichannel
activity is potently inhibited by thrombin in BCEC transfected
with scrambled siRNA-duplex (Fig. 6B). These results demonstrate
that RhoA GTPase activity is involved in the thrombin-induced
inhibition of Cx hemichannels in BCEC.
To demonstrate the involvement of Cx43-made channels in the
downstream cascade of activated RhoA, we performed Ca2z-
wave propagation experiments with thrombin in conditions where
RhoA and Cx43 were simultaneously knocked down. siRhoA-1
does not completely rescue the active area in the presence of
thrombin when Cx43 is knocked down. The results show that
Cx43 is involved in the RhoA-signaling cascade because the
siRhoA-mediated alleviation of thrombin-induced Ca2z-wave
propagation was significantly reduced by siCx43, and the
reduction is significantly larger than the active area of the
condition with thrombin-stimulated cells that were transfected
with control siRNA (scramble-1) (Fig. 7).
Since the knock-down approach with siRNA against Cx43
affects both Cx43-hemichannel- and - gap junction-mediated
signaling, we performed additional experiments to investigate an
eventual contribution of the gap junctional pathway, although it
was previously demonstrated that the gap junctional pathway only
has a limited contribution to intercellular Ca2z-waves propaga-
tion in BCEC ([8,10,11,20]. Therefore, we investigated the effect
of thrombin in conditions of RhoA-knockdown where intercellular
Ca2z-wave propagation mediated by Cx43 hemichannels was
inhibited while gap junctional communication was unaffected. In a
first set of experiments, we applied the TAT-Cx43L2 peptide. This
Cx43-mimetic peptide, derived from a sequence located in the
intracellular loop of Cx43, has been validated to selectively block
Cx43-hemichannels while maintaining gap junctional coupling
[10,21] (Fig. 7). TAT-Cx43L2 potently reduced the active area of
the Ca2z-wave in siRhoA-1 treated cells. No significant further
reduction was detected when also thrombin was applied to these
cells, which confirms the involvement of Cx43-hemichannels in
the signaling cascade.
In another set of experiments, we investigated the effect of
thrombin after knock-down of RhoA when ATP-dependent
paracellular communication was blocked by extracellular apyrases
(Fig. 7). A mixture of ectonucleotidases apyrase VI (5 U/ml) and
VII (5 U/ml) was used, which is known to potently block all ATP/
ADP dependent purinergic signaling and to strongly reduce
propagation of the Ca2z wave in monolayers of BCEC [9–11].
Blocking the Cx hemichannel-mediated ATP-dependent paracrine
pathway after RhoA knock-down by either TAT-Cx43L2 or
apyrases resulted in an active area that was strongly reduced
without further reduction of the active area upon thrombin
treatment (Fig. 7). This demonstrates that the effect of RhoA
knock-down is virtually exclusively mediated via the pathway that
involves ATP-dependent paracrine intercellular communication
through Cx43 hemichannels. The results of these experiments
indicate that knockdown of RhoA upon blocking the purinergic
signaling in a Cx43-dependent and -independent manner while
maintaining gap junctional coupling does not significantly oppose
the thrombin-induced inhibition of Ca2z-wave propagation. This
suggests that possible contribution of activated RhoA in inhibiting
Cx43 gap junctional coupling in thrombin-treated BCEC is
negligible (Fig. 7). These findings, taken together with our previous
finding that thrombin inhibits Cx43-hemichannel responses in
BCEC [10] by enhanced contractility [13], provide evidence that
RhoA is a key component in contractility-induced-inhibition of
Cx43-hemichannel responses.
Discussion
The most important finding of this study is that RhoA is an
essential component of the signaling cascade that controls
Figure 2. Effect of C3-pretreatment on the thrombin-inhibited release of ATP in BCEC. Quantitative measurement of mechanical stimulus-
induced ATP release using the bioluminescence luciferin-luciferase assay. (A) Mean number of light counts under baseline (no stimulation) and after
mechanical stimulation (control condition) were quantified (N= 5, n = 11). (B) Normalized ATP release after mechanical stimulation of untreated (white
bars) and thrombin-treated (black bars) BCEC, either in control conditions (N= 5, n = 11) or in C3-toxin-pretreated conditions (N = 5, n = 9), is shown.
 indicates that thrombin significantly (pv 0.001) inhibits Ca2z-wave propagation. ‘ indicates that C3-toxin significantly (pv 0.001) alleviates the
thrombin-induced inhibition of Ca2z-wave propagation.
doi:10.1371/journal.pone.0042074.g002
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Figure 3. LY-uptake after C3-pretreatment in the absence and presence of thrombin. Non-confluent grown BCEC were exposed to the
hydrophilic Lucifer Yellow dye (2.5% for 5 min) in a PBS-buffer containing 2 mM EGTA. Left panels represent the fluorescence signal of LY while the
cells are visualized by differential interference contrast (DIC) microscopy (right panels). (A) Uptake of LY in control condition (N= 4, n = 20). (B) LY-
uptake is blocked in BCEC treated with thrombin (2 U/ml) for 5 min (N= 4, n = 20). (C) LY-uptake after pretreatment with C3 (2 mg/ml) for 3 hours
(N = 4, n = 20). (D) C3 prevents significant LY-uptake after thrombin-treatment (N = 4, n = 20). The approximate percentage of cells that accumulated
the dye was determined for each condition by manually counting the number of LY-positive and LY-negative cells (n = 200 cells). Cells were
considered LY-positive or -negative as indicated in the box.
doi:10.1371/journal.pone.0042074.g003
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inhibition of Cx43-hemichannel activity through contractility and
the hemichannel-mediated ATP-dependent paracrine intercellular
communication. We show that RhoA is activated upon exposure
of BCEC to thrombin and that chemical inhibition of RhoA
activity with C3 and genetic inhibition of RhoA expression with
siRNA alleviates the inhibition of Cx43 hemichannels by increased
contractility in BCEC induced by thrombin exposure. These
findings are important, since the Rho-ROCK signaling axis
controls the thrombin-induced activation of contractility by non-
muscle myosin II. Our findings indicate that thrombin activates
RhoA in BCEC cells and that C3-treatment prevents the
inhibitory effect of thrombin on intercellular communication as
assayed by Ca2z-wave propagation, ATP release and LY-uptake.
The C3-transferase of Clostridium botulinum is known to covalently
modify RhoA, RhoB and RhoC GTPases by mono-ADP-
ribosylation. This event inactivates these Rho GTPases by
Figure 4. Thrombin-stimulated RhoA activity in BCEC lysates as a function of time. Transient RhoA activation in BCEC after treatment with
thrombin (2 U/ml). Freshly prepapred lysates from BCEC before thrombin exposure (0 min) and after 0.5 min, 1 min, 3 min, 5 min and 15 min after
thrombin exposure were assessed. Active RhoA was isolated using GST-Rhotekin-RBD beads following the manufacturer’s protocol. In vitro GTPcS-
loaded RhoA was used as a positive control (square inset). Both the active RhoA levels as well as the total RhoA levels were analyzed by
immunoblotting using anti-RhoA. The double lines indicate samples were taken from a different part from the same blot and exposure. (B)
Quantitative analysis of 3 independent experiments, in which the activated RhoA signals were normalized to the signal of the maximal activatable
RhoA obtained using GTPcS treatment. Data represent mean + S.E.M.
doi:10.1371/journal.pone.0042074.g004
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preventing nucleotide exchange [18]. Pre-treatment of BCEC for
3 hours caused robust ADP-ribosylation of RhoA, which is
characterized by an increase in molecular weight and subsequently
a shift in migration-pattern that becomes clear after RhoA-
immunoblotting. Since we demonstrated that pre-treatment of the
cells with the C3-exoenzyme prevents the thrombin-induced
inhibition of Cx43-hemichannel responses without significantly
affecting intercellular Ca2z-wave propagation and mechanically-
induced ATP-release from BCEC in the absence of thrombin, Rho
GTPases are clearly involved in the intracellular signaling cascade
that brings about contractility-induced inhibition of Cx43-hemi-
channel activity (Figs. 1 and 2). These results, which are in line
with dye uptake experiments performed with BCEC that were
pretreated with C3 (Fig. 3), indicate that at least one Rho GTPase
is involved in the thrombin-induced inhibition of Cx43-channel
activity in BCEC. By performing reverse-transcriptase PCR
experiments we detected the presence of RhoA and RhoB in
BCEC. These results were confirmed by Western blot analysis
(data not shown). The presence of the Rho GTPase effector
ROCK-II ( = ROKa) but not ROCK-I ( = ROKb = p160-
ROCK) was detected in BCEC at the mRNA-level (data not
shown). Since it is known that the ROCK-II-inhibitor Y-27632
could prevent the inhibitory effects of thrombin on Cx43-mediated
gap junction - and hemichannel activity [11], it is very likely that
ROCK-II is a major effector kinase in the signaling cascade that
causes actomyosin contractility in BCEC. We propose that RhoA
has an essential role in the studied signaling cascade (presented in
Fig. 8) because we found that i) RhoA-GTPase activity is rapidly
and transiently increased within 1 minute after thrombin exposure
of BCEC, ii) C3-treatment, which prevented RhoA activation,
alleviated thrombin-induced inhibition of Cx43-hemichannel
responses, and iii) suppressing RhoA expression using siRNA
completely alleviated thrombin-induced inhibition of Cx43-chan-
nel responses. Therefore, we propose that RhoA GTPases act as a
molecular switch that controls the onset of thrombin-induced
actomyosin contractility causing the potent inhibition of Cx43-
hemichannel activity and subsequent ATP release. Furthermore,
while several studies described that thrombin-induced signaling
through RhoA leads to ATP release [22–28], our result indicate
that RhoA activation in response to thrombin can prevent ATP
release. The apparent discrepancy between both observations may
be due to a difference in the molecular signaling intermediates (e.g.
ROCK independent) [22,23] and release mechanisms (e.g.
exocytosis) [26] that are responsible for ATP release. While
Cx43 hemichannels are inhibited by thrombin-induced signaling
by activation of the actomyosin cytoskeleton, other Cx or Panx
isoforms may not or differentially be influenced through this
pathway [27]. In this respect, a recent report from thrombin-
treated human umbilical vein endothelial cells showed that
thrombin induced ATP release was mediated by Panx1 channels,
but not by Cx43 hemichannels [28].
While our findings suggest that possible contribution of
activated RhoA in inhibiting Cx43 gap junctional coupling in
thrombin-treated BCEC is likely negligible or at least difficult to
detect, we do not exclude that in other cell-systems activated
RhoA might be able to potently regulate gap junctional coupling.
Moreover, data from various authors underpin the concept that
Rho GTPases and cytoskeletal reorganization are often involved in
mechanisms that influence gap junctional - or hemichannel-
mediated communication [22–24,27–29].
Recently, we have documented possible mechanisms and
relevance by which enhanced actomyosin contractility could
negatively regulate Cx43 hemichannel responses [30]. Experi-
ments with C-terminal peptides of Cx43 (TAT-Cx43CT10) in cells
that overexpress either wild-type Cx43 or C-terminal truncated
Cx43 identified the C-terminal tail of Cx43-hemichannels as a
potential link to the contractile system and indicate that
contractility disrupts Cx43 loop/tail interactions that are essential
for ensuring proper Cx43 hemichannel responses [10]. While the
exact molecular mechanism has not yet been resolved, the C-
terminal tail of Cx43 channels in the hemichannel-conformation
could sense enhanced actomyosin contractility in either a direct or
indirect manner. One or more Cx43-binding proteins that interact
with the C-terminal tail could provide the link with the actin
cytoskeleton. The C-terminal tail might also be indirectly coupled
to the actin cytoskeleton by interacting with another membrane-
associated protein that senses the actomyosin contractility.
Furthermore, it remains to be investigated whether thrombin
causes a redistribution of Cx43-channels within the plasma
membrane or increases internalization by an actomyosin-depen-
dent mechanism. Anderson et al. described that inhibition of
ROCK by Y-27623 increased the number of Cx43 gap junctions
and improved gap junctional intercellular communication be-
tween rabbit corneal epithelial cells [31]. In addition, GPCR-
activation induced GJ-channel closure within 1–2 minutes [32],
while GJ-internalization can occur within 10 to 20 minutes [33].
PAR-1 activation by thrombin rapidly inhibited GJ-channels,
which coincided with the internalization of gap junctions in
porcine pulmonary artery endothelial cells. The mechanism
appears to involve the endocytosis-associated vesicle-coat protein
clathrin and the cytoskeleton-associated scaffold ZO-1 [33].
Our results obtained by experiments with pharmacological
inhibitors (Y-27623 and blebbistatin) [10,11,13], which act
downstream of RhoA, indicate that contractility mediated by the
actomyosin II system is essential for the thrombin-induced
inhibition of Cx43 hemichannels. These data largely exclude that
a contractility-independent effect of RhoA causes the inhibition of
Cx43-hemichannels by thrombin.
In conclusion, our current findings demonstrate that besides the
previously identified Rho-associated kinase [11], MLC phosphor-
ylation [11,13] and actomyosin II-mediated contractility [13],
RhoA activation is an essential step in the cascade underlying
thrombin-induced inhibition of Cx43-hemichannel-mediated ATP
Figure 5. Thrombin-stimulated RhoA activity in BCEC after C3-
pretreatment. Western-blot analysis of RhoA activity after BCEC
exposure to thrombin (0.5, 1.5 and 15 min) obtained from lysates of
untreated BCEC and BCEC pretreated for 3 hours with C3 at 37uC. Active
RhoA fraction was isolated from freshly prepared BCEC lysates using
GST-Rhotekin-RBD beads following the manufacturer’s protocol (upper
blot). In vitro GTPcS-loaded RhoA was used as a positive control. The
total RhoA levels were determined in all lysates (lower blot).
doi:10.1371/journal.pone.0042074.g005
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release through activation of actomyosin contractile system
[6,10,30] (Fig 8).
Materials and Methods
Cell Culture
Primary cultures of BCEC were established as previously
described [8,11,13]. First and second passage cells were seeded
into two-chambered glass slides (155380; Nunc, Roskilde, Den-
mark) at a density of 165,000 cells per chamber (4.2 cm2) and were
grown for three to four days to reach confluence.
Chemicals
Fluo-4 AM (F14217), Dulbecco’s PBS (14190-091), Dulbecco’s
modified Eagle’s medium (DMEM, 11960-044), L-glutamine
(Glutamax, 35050-038), antibiotic antimycotic mixture (15240-
096), EBSS (Earle’s balanced salt solution, 14155-048), and trypsin
(25300-054) were obtained from Invitrogen-Gibco. Fetal bovine
serum (F-7524), a luciferin-luciferase bioluminescence assay kit
(FL-AAM), ATP, thrombin (T-4648), apyrase VI (A6410), apyrase
VII (A6535) and LY (L-0259) were obtained from Sigma-Aldrich
(Deisenhofen, Germany). The cell-permeable Rho inhibitor
exoenzyme C3-transferase (CT04), referred to as ‘‘C3’’, was
obtained from Cytoskeleton, Inc (Denver, CO, USA).
TAT-Cx43L2 Peptide
TAT-Cx43L2 peptide (85% pure) was obtained from Lifetein
(South Plainfield, NJ, USA). TAT-Cx43L2
(YGRKKRRQRRRDGANVDMHLKQIEIKKFKYGIEEHGK)
was used at 100 mM and incubated with the cells for 30 min at
37uC as described previously [10].
Imaging of Ca2z-wave Propagation
The protocol for point mechanical stimulation of a single cell
has been described in our previous studies [8,11,13]. The
mechanical stimulation consisted of an acute deformation of a
cell by briefly touching less than 1% of its cell membrane with a
Figure 6. Effect of RhoA knockdown on thrombin-induced inhibition of mechanical stimulus-induced Ca2+-wave propagation in
BCEC. (A) Representative Western-blot analysis showing total RhoA-protein levels in total cell lysates (20 mg/lane) of BCEC treated with siRNA-1
against RhoA (siRhoA-1), siRNA-2 against RhoA (siRhoA-2) and siRNA representing a scrambled version of siRNA-1 against RhoA (scramble-1). (B)
Quantitative analysis of the total spreading of the mechanical stimulation-triggered Ca2z-wave in siRNA treated cells, presented as active area (AA)
normalized to the untreated (white bar) scramble-1 condition (100%). Comparison of the thrombin-treated conditions (black bars) indicates that both
siRhoA-1 and siRhoA-2 independently and significantly alleviated the thrombin-induced inhibition of the AA of the intercellular Ca2z-wave
propagation in comparison to scramble-1-treated samples (, p v 0.001) (N = 3, n = 30).
doi:10.1371/journal.pone.0042074.g006
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glass micropipette (tip diameter v 1 mm) coupled to a
piezoelectric crystal (Piezo device P-280, Amplifier-E463; PI
Polytech, Karlsruhe, Germany). The Ca2z-wave propagation
was assayed by imaging ½Ca2zi. Therefore, BCEC were loaded
with the Ca2z-sensitive fluorescent dye Fluo-4-AM for 30 min at
37uC on a rocking shaker (& 10 rpm). BCEC were pre-incubated
in the presence (2 mg/ml) or absence of the cell-permeable Rho
inhibitor (C3) for three hours at 37uC and 5% CO2. Pre-
incubation, Fluo-4 loading and experiments were performed in
PBS containing 0.9 mM Ca2z and 25 mM glucose. After Fluo-4
loading, BCEC were exposed to thrombin (2 U/ml) and ½Ca2zi
levels were allowed to recover to basal levels before performing the
Ca2z-wave propagation experiment. Fluo-4 was excited at
488 nm, and its fluorescence emission was collected at 530 nm.
Spatial changes in ½Ca2zi following point mechanical stimulation
were measured with the confocal microscope (LSM510) using a
40X objective (1.3 NA). Intercellular propagation of the Ca2z
wave was characterized by the total surface area of responsive cells
(active area, AA) with normalized fluorescence ƒ1:1 using
imaging software (LSM Image 4.2, Zeiss).
Lucifer Yellow Uptake Assay
BCEC were treated with cell-permeable C3 (2 mg/ml) for 3
hours under same physiological conditions as used for Ca2z-wave
propagation. Then, cells were incubated in LY-solution (PBS
solution containing 2 mM EGTA and 2.5% LY) for 5 min. In
experiments with thrombin, cells were exposed to thrombin for
one minute before exposure to LY. Dye uptake was recorded using
the confocal microscope (LSM510; Carl Zeiss) by excitation at
488 nm with emission recorded at 530 nm as described previously
[11–13].
Measurement of ATP Release
ATP release induced by mechanical stimulation (performed on
the confocal microscope for visualization of the stimulus), was
measured using the luciferin-luciferase bioluminescence technique
as previously described [8,11,12]. Aliquots of 100ml were taken
from the 500 ml bathing solution covering the cells, and transferred
to a custom-built photo-counting setup [13] for quantification of
ATP-amount. BCEC were treated with C3 for 3 hours under same
physiological conditions as used for Ca2z-wave propagation.
RhoA-activity Assay
Activation of Rho GTPase was examined by GST pull-down of
GTP-bound Rho proteins by using the Rho-binding domain
(RBD) of Rhothekin protein (an effector of RhoA) expressed as a
GST-fusion protein and coupled to agarose beads (RT02,
Cytoskeleton, Inc.) to capture the active (GTP-bound) Rho
proteins in BCEC-lysates. Pull down samples were subjected to
SDS-PAGE and Western-blotting analysis. Active and total RhoA
levels were visualized after immunoblotting with a primary rabbit
monoclonal anti-RhoA antibody (clone 67B9, 2117, Cell Signaling
Technology, Beverly, MA, USA).
Knock-down of RhoA and Cx43 by siRNA
Screening for potent siRNA-oligonucleotides, with exclusion of
off-target candidates to selectively knock-down RhoA in BCEC,
was performed using the RNAi batch selector [34] on a FreeBSD
system. Two siRNA-duplexes that target different regions of RhoA
mRNA (sense siRhoA-1:59CUAUGUGGCAGAUAUUGAdTdT;
sense siRhoA-2:59UUAGGCUGUAACUACUUUAdTdT) were
selected for experiments and negative control was designed (sense
ScramRhoA-1:59CUUAUAGGAUAGUGUAACAdTdT). An-
nealed siRNA was purchased from Eurogentec (Liege, Belgium)
and BCEC were transfected with siRNA duplexes (80 nM final)
Figure 7. Effect of Cx43 knockdown, TAT-Cx43L2 and apyrase treatment on the siRhoA-opposed thrombin-induced inhibition of
Ca2+-wave propagation in BCEC. Quantitative analysis of the total spreading of the mechanical stimulation-triggered Ca2z-wave in
thrombin-treated cells as active area (AA) normalized to the untreated (no thrombin, white bar) scramble-1 condition (100%). Knockdown of RhoA by
siRhoA-1 significantly prevented the thrombin-induced inhibition of Ca2z-wave propagation (, p v 0.001). Simultaneous knock down of Cx43
(siCx43) and RhoA (siRhoA-1) significantly reduced the normalized AA when compared to siRhoA-1 only or siRhoA-1 plus scr-2. Scr-2 represents
treatment with a scrambled version of siCx43 siRNA. Experiments with siRNA-treated cells in the presence of either TAT-Cx43L2 or apyrase show that
both TAT-Cx43L2 and apyrase potently reduced the normalized AA in BCEC upon RhoA knockdown in the presence (
ˆ
, pv 0.001, i.e. comparison of
black bars) and absence of thrombin (N= 3, n = 30).
doi:10.1371/journal.pone.0042074.g007
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for 6 hours in Optimem medium (Invitrogen) using HiPerfect
transfection reagent (Qiagen, Venlo, The Netherlands). Knock-
down was examined by Western blot analysis using a rabbit
monoclonal (clone 67B9) anti-RhoA antibody (Cell Signaling
Technology). BCEC were transfected with si1Cx43 duplex or its
negative control (scr-2) at 80 nM final, as previously described and
validated (sense siCx43-1:59GAAGGAGGAGGAACU-
CAAAdTdT, sense scr-2:59GGUAAACGGAACGAGAA-
GAdTdT) [10].
Data Analysis
One-way ANOVA was used to compare the mean values for
different treatments while unpaired tests were used to compare
results of experiments with a single treatment and a single control.
A p value of v 0.05 is considered statistically significant.
Histograms are expressed as mean + standard error of the mean
(SEM). ‘‘N’’ indicates the number of independent experiments,
while ‘‘n’’ represents the total number of mechanically stimulated
cells.
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Figure 8. Signal-transduction cascade of thrombin-induced inhibition of Cx43 hemichannel opening in BCEC. Thrombin-mediated
activation of the cell-surface-expressed protease-activated receptor-1 (PAR-1) affects the MLC phosphorylation-state through multiple intracellular
signaling pathways. The effector response of PAR-1 depends on the isoform of the Ga subunit (i.e. Gaq/11 or Ga12/13) that is coupled to this G-
protein-coupled receptor. These pathways include PKC-dependent signaling, IP3-dependent Ca
2z rise and activation of the Ca2z-sensitization
pathway via RhoA-ROCK signaling. Enhanced MLC-phosphorylation leads to increased actomyosin II dependent contractility and subsequently
inhibition of Cx43 hemichannel opening. The findings in this study described that RhoA activation is essential to cause contractility-induced
inhibition of the Cx43 hemichannel. References, included in the figure within italic brackets, indicate in which study we provide the supporting
experimental data.
doi:10.1371/journal.pone.0042074.g008
RhoA Controls Cx43 Hemichannels in Contractility
PLoS ONE | www.plosone.org 9 July 2012 | Volume 7 | Issue 7 | e42074
References
1. Sa´ez JC, Schalper KA, Retamal MA, Orellana JA, Shoji KF, et al. (2010) Cell
membrane permeabilization via connexin hemichannels in living and dying cells.
Exp Cell Res 316: 2377–2389.
2. Retamal MA, Froger N, Palacios-Prado N, Ezan P, Sa´ez PJ, et al. (2007) Cx43
hemichannels and gap junction channels in astrocytes are regulated oppositely
by proin–ammatory cytokines released from activated microglia. J Neurosci 27:
13781–13792.
3. Orellana JA, Sa´ez PJ, Shoji KF, Schalper KA, Palacios-Prado N, et al. (2009)
Modulation of brain hemichannels and gap junction channels by pro-
inflammatory agents and their possible role in neurodegeneration. Antioxid
Redox Signal 11: 369–399.
4. Retamal MA, Schalper KA, Shoji KF, Orellana JA, Bennett MVL, et al. (2007)
Possible involvement of different connexin 43 domains in plasma membrane
permeabilization induced by ischemiareperfusion. J Membr Biol 218: 49–63.
5. Retamal MA, Schalper KA, Shoji KF, Bennett MVL, Sa´ez JC (2007) Opening
of connexin 43 hemichannels is increased by lowering intracellular redox
potential. Proc Natl Acad Sci U S A 104: 8322–8327.
6. Ponsaerts R, D’hondt C, Gomes P, Bultynck G, Srinivas SP, et al. (2010)
Extracellular ATP and adenosine as regulators of endothelial cell function:
Implications for health and disease, Springer Science, volume 1, chapter 10:
ATP release via connexin hemichannels controls intercellular propagation of
Ca2+ waves in corneal endothelial cells. 1st edition, 161–203.
7. Srinivas SP (2010) Dynamic regulation of barrier integrity of the corneal
endothelium. Optom Vis Sci 87: E239–E254.
8. Gomes P, Srinivas SP, Van Driessche W, Vereecke J, Himpens B (2005) ATP
release through connexin hemichannels in corneal endothelial cells. Invest
Ophthalmol Vis Sci 46: 1208–1218.
9. Gomes P, Srinivas SP, Vereecke J, Himpens B (2005) ATP-dependent paracrine
intercellular communication in cultured bovine corneal endothelial cells. Invest
Ophthalmol Vis Sci 46: 104–113.
10. Ponsaerts R, De Vuyst E, Retamal M, D’hondt C, Vermeire D, et al. (2010)
Intramolecular loop/tail interactions are essential for connexin 43-hemichannel
activity. FASEB J 24: 4378–4395.
11. D’hondt C, Ponsaerts R, Srinivas SP, Vereecke J, Himpens B (2007) Thrombin
inhibits intercellular calcium wave propagation in corneal endothelial cells by
modulation of hemichannels and gap junctions. Invest Ophthalmol Vis Sci 48:
120–133.
12. D’hondt C, Srinivas SP, Vereecke J, Himpens B (2007) Adenosine opposes
thrombin-induced inhibition of intercellular calcium wave in corneal endothelial
cells. Invest Ophthalmol Vis Sci 48: 1518–1527.
13. Ponsaerts R, D’hondt C, Bultynck G, Srinivas SP, Vereecke J, et al. (2008) The
myosin II ATPase inhibitor blebbistatin prevents thrombin-induced inhibition of
intercellular calcium wave propagation in corneal endothelial cells. Invest
Ophthalmol Vis Sci 49: 4816–4827.
14. Satpathy M, Gallagher P, Lizotte-Waniewski M, Srinivas SP (2004) Thrombin-
induced phosphorylation of the regulatory light chain of myosin II in cultured
bovine corneal endothelial cells. Exp Eye Res 79: 477–486.
15. Somlyo AP, Somlyo AV (2003) Ca2+ sensitivity of smooth muscle and non-
muscle myosin II: modulated by G-proteins, kinases, and myosin phosphatase.
Physiol Rev 83: 1325–1358.
16. Birukova AA, Smurova K, Birukov KG, Kaibuchi K, Garcia JGN, et al. (2004)
Role of Rho GTPases in thrombin-induced lung vascular endothelial cells
barrier dysfunction. Microvasc Res 67: 64–77.
17. Vouret-Craviari V, Grall D, Obberghen-Schilling EV (2003) Modulation of rho
GTPase activity in endothelial cells by selective proteinase-activated receptor
(PAR) agonists. J Thromb Haemost 1: 1103–1111.
18. Aktories K, Wilde C, Vogelsgesang M (2004) Rho-modifying C3-like ADP-
ribosyltransferases. Rev Physiol Biochem Pharmacol 152: 1–22.
19. van Nieuw Amerongen GP, van Delft S, Vermeer MA, Collard JG, van
Hinsbergh VW (2000) Activation of RhoA by thrombin in endothelial
hyperpermeability: role of Rho kinase and protein tyrosine kinases. Circ Res
87: 335–340.
20. Gomes P, Srinivas SP, Vereecke J, Himpens B (2006) Gap junctional
intercellular communication in bovine corneal endothelial cells. Exp Eye Res
83: 1225–1237.
21. Stehberg J, Moraga-Amaro R, Salazar C, Becerra A, Echeverrı´a C, et al. (2012)
Release of gliotransmitters through astroglial connexin 43 hemichannels is
necessary for fear memory consolidation in the basolateral amygdala.
FASEB J Epub.
22. Kreda SM, Seminario-Vidal L, van Heusden C, Lazarowski ER (2008)
Thrombin-promoted release of UDP-glucose from human astrocytoma cells.
Br J Pharmacol 153: 1528–1537.
23. Blum AE, Joseph SM, Przybylski RJ, Dubyak GR (2008) Rho-family GTPases
modulate ca2+- dependent ATP release from astrocytes. Am J Physiol Cell
Physiol 295: C231–C241.
24. Seminario-Vidal L, Kreda S, Jones L, O’Neal W, Trejo J, et al. (2009)
Thrombin promotes release of ATP from lung epithelial cells through
coordinated activation of Rho- and Ca2+-dependent signaling pathways. J Biol
Chem 284: 20638–20648.
25. Blum AE, Walsh BC, Dubyak GR (2010) Extracellular osmolarity modulates G
protein-coupled receptor-dependent ATP release from 1321n1 astrocytoma
cells. Am J Physiol Cell Physiol 298: C386–C396.
26. Kreda SM, Seminario-Vidal L, van Heusden CA, O’Neal W, Jones L, et al.
(2010) Receptorpromoted exocytosis of airway epithelial mucin granules
containing a spectrum of adenine nucleotides. J Physiol 588: 2255–2267.
27. Seminario-Vidal L, Okada SF, Sesma JI, Kreda SM, van Heusden CA, et al.
(2011) Rho signaling regulates pannexin 1-mediated ATP release from airway
epithelia. J Biol Chem 286: 26277–26286.
28. Goedecke S, Roderigo C, Rose CR, Rauch BH, Goedecke A, et al. (2011)
Thrombin-induced ATP release from human umbilical vein endothelial cells.
Am J Physiol Cell Physiol 0.
29. Derangeon M, Bourmeyster N, Plaisance I, Pinet-Charvet C, Chen Q, et al.
(2008) RhoA GTPase and F-actin dynamically regulate the permeability of
Cx43-made channels in rat cardiac myocytes. J Biol Chem 283: 30754–30765.
30. Ponsaerts R, Wang N, Himpens B, Leybaert L, Bultynck G (2012) The
contractile system as a negative regulator of the connexin 43 hemichannel. Biol
Cell Epub.
31. Anderson SC, Stone C, Tkach L, SundarRaj N (2002) Rho and Rho-kinase
(ROCK) signaling in adherens and gap junction assembly in corneal epithelium.
Invest Ophthalmol Vis Sci 43: 978–986.
32. van Zeijl L, Ponsioen B, Giepmans BNG, Ariaens A, Postma FR, et al. (2007)
Regulation of connexin 43 gap junctional communication by phosphatidylino-
sitol 4,5-bisphosphate. J Cell Biol 177: 881–891.
33. Baker SM, Kim N, Gumpert AM, Segretain D, Falk MM (2008) Acute
internalization of gap junctions in vascular endothelial cells in response to in–
ammatory mediator-induced G-protein coupled receptor activation. FEBS Lett
582: 4039–4046.
34. Iyer S, Deutsch K, Yan X, Lin B (2007) Batch RNAi selector: a standalone
program to predict specific siRNA candidates in batches with enhanced
sensitivity. Comput Methods Programs Biomed 85: 203–209.
RhoA Controls Cx43 Hemichannels in Contractility
PLoS ONE | www.plosone.org 10 July 2012 | Volume 7 | Issue 7 | e42074
